Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

(NASDAQ:ALDX) LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. Dr. Brady’s conversation with Matthew Caufield, Director, Eq